Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer
| Autor: | Gonzalez-Angulo, Ana M., Lei, Xiudong, Alvarez, Richardo H., Green, Majorie C., Murray, James L., Valero, Vicente, Koenig, Kimberly B., Ibrahim, Nuhad K., Litton, Jennifer K., Nair, Lakshmy, Krishnamurthy, Savitri, Hortobagyi, Gabriel N., Meric-Bernstam, Funda |
|---|---|
| Zdroj: | In Clinical Breast Cancer October 2015 15(5):325-331 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect